What is Barclays's price target for DH?

Barclays's latest stated price target for Definitive Healthcare Corp. (DH) is $4, from its action on Jan 13, 2025.

What is Barclays's rating on DH?

Barclays rates DH Underweight, a bearish rating, as of Jan 13, 2025.

When did Barclays last change its view on DH?

On Jan 13, 2025, Barclays downgrades to Underweight from Equal Weight, price target $4.

Barclays DH price target and rating history

Definitive Healthcare Corp. (DH) · Technology

Barclays rates Definitive Healthcare Corp. (DH) Underweight with a $4 price target, as of its latest action on Jan 13, 2025. It has published 3 rating actions on DH since October 2021, including 0 upgrades and 1 downgrade.

Current rating: Underweight
Price target: $4
Median target, all firms: Too few
Actions on DH: 3

Barclays price target on DH

Barclays price target on DH, each point a stated target, October 2021 to January 2025.

Every Barclays rating on DH

Jan 13, 2025
DowngradeBarclays downgrades to Underweight from Equal Weight, price target $4
Jan 19, 2022
ReiterateBarclays cuts its price target to $26 from $47, keeps Equal-Weight
Oct 11, 2021
InitiateBarclays starts coverage at Equal-Weight, price target $47

Questions about Barclays and DH

What is Barclays's price target for DH?: Barclays's latest stated price target for Definitive Healthcare Corp. (DH) is $4, from its action on Jan 13, 2025.
What is Barclays's rating on DH?: Barclays rates DH Underweight, a bearish rating, as of Jan 13, 2025.
When did Barclays last change its view on DH?: On Jan 13, 2025, Barclays downgrades to Underweight from Equal Weight, price target $4.

More DH rating histories

All Barclays ratings DH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.